BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8685095)

  • 1. [DNA cytometry of solitary and aneurysmal bone cysts and low malignancy and high malignancy central osteosarcomas. Current significance within the scope of morphologic diagnosis of intraosseous cystic and osteoblastic lesions].
    Werner M; Heintz A; Delling G
    Pathologe; 1996 Jan; 17(1):44-9. PubMed ID: 8685095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
    el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
    Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors.
    Takeshita H; Kusuzaki K; Kuzuhara A; Tsuji Y; Ashihara T; Gebhardt MC; Mankin HJ; Springfield DS; Hirasawa Y
    Anticancer Res; 2001; 21(2B):1271-7. PubMed ID: 11396198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric determination of DNA content in malignant and benign bone tumours.
    Heliö H; Karaharju E; Nordling S
    Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative DNA cytometric investigations on aneurysmal bone cysts and giant cell tumors].
    Werner M; Delling G
    Pathologe; 2002 Sep; 23(5):340-50. PubMed ID: 12376859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell proliferation in bone tumors. Immunohistologic study of Ki-67 protein expression].
    Stenzel I; Pösl M; Ritzel H; Hentz M; Werner M; Delling G
    Pathologe; 1996 Jan; 17(1):56-62. PubMed ID: 8685097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic changes in low grade central osteosarcomas].
    Werner M; Rieck J; Delling G
    Verh Dtsch Ges Pathol; 1998; 82():189-94. PubMed ID: 10095432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
    Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group.
    Sciot R; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Tallini G; Van den Berghe H; Vanni R; Willén H
    Mod Pathol; 2000 Nov; 13(11):1206-10. PubMed ID: 11106078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cytomorphologic methods in the diagnosis of bone tumors: possibilities and limitations.
    Roessner A; Mellin W; Hiddemann W; Voss B; Vollmer E; Grundmann E
    Semin Diagn Pathol; 1984 Aug; 1(3):199-214. PubMed ID: 6600111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor heterogeneity in osteosarcoma as identified by flow cytometry.
    Hiddemann W; Roessner A; Wörmann B; Mellin W; Klockenkemper B; Bösing T; Büchner T; Grundmann E
    Cancer; 1987 Jan; 59(2):324-8. PubMed ID: 3467822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA cytometry and automation in clinical diagnostics].
    Böcking A
    Verh Dtsch Ges Pathol; 1990; 74():176-85. PubMed ID: 1708579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Giant cell tumor of bone. Morphological, immunohistochemical, morphometric and DNA flow cytometric findings].
    Kröber SM; Greschniok A; Böhm P; Kaiserling E
    Verh Dtsch Ges Pathol; 1998; 82():279-83. PubMed ID: 10095447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic instability in osteoblastic tumors of the skeletal system.
    Radig K; Schneider-Stock R; Mittler U; Neumann HW; Roessner A
    Pathol Res Pract; 1998; 194(10):669-77. PubMed ID: 9820862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cytogenetics, interphase cytogenetics, and DNA flow cytometry in bone tumors.
    Tarkkanen M; Nordling S; Böhling T; Kivioja A; Karaharju E Szymanska J; Elomaa I; Knuutila S
    Cytometry; 1996 Sep; 26(3):185-91. PubMed ID: 8889389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization of low-grade central osteosarcoma.
    Tarkkanen M; Böhling T; Gamberi G; Ragazzini P; Benassi MS; Kivioja A; Kallio P; Elomaa I; Picci P; Knuutila S
    Mod Pathol; 1998 May; 11(5):421-6. PubMed ID: 9619593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA cytometry of osteosarcoma.
    Bauer HC
    Acta Orthop Scand Suppl; 1988; 228():1-39. PubMed ID: 3063059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign and malignant eccrine poroma--a flow cytometric comparison.
    Hagler J; Trattner A; Nativ O; Hauben DJ; David M
    Isr J Med Sci; 1996 Dec; 32(12):1151-3. PubMed ID: 9007142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.